Stamford, CT—March 21, 2017
Charles "Chip" Cornell, MD, has been named Chair of the newly created Department of Orthopedic Surgery at Stamford Health, effective March 1. As Department Chair, Dr. Cornell will be responsible for the direction of all orthopedic services, including subspecialty divisions and HSS Orthopedics at Stamford Health. The hospital’s new collaboration with Hospital for Special Surgery was announced last month.
On Tuesday, March 7, Dr. Cornell successfully completed the first surgery under the collaboration, officially launching a new era of advanced orthopedic care in Connecticut and New England.
"We are proud to have someone of Dr. Cornell’s recognized leadership and surgical expertise join Stamford Health as we expand orthopedic services," said Sharon Kiely, MD, Senior Vice President of Medical Affairs and Chief Medical Officer at Stamford Health. "This follows the announcement of our collaboration with Hospital for Special Surgery and complements our vision of further developing leading specialty services in orthopedics."
Dr. Cornell is Professor of Clinical Orthopedic Surgery at Weill Cornell Medical College and an Attending Orthopedic Surgeon at Hospital for Special Surgery. He served as Clinical Director of Orthopedics for HSS beginning in 2006, and holds the Richard Laskin, MD, Chair in Orthopedic Surgery since 2011. Dr. Cornell has been active in the Resident and Medical School program throughout his career and recognized for his dedication to education, receiving the Philip Wilson Teaching Award three times.
Dr. Cornell is Editor-In-Chief of the HSS Journal and Associate Editor of Clinical Orthopedics and Related Research. Throughout his career, Dr. Cornell has studied the outcome of total knee replacement as treatment for osteoarthritis of the knee. His current research interests include investigating novel approaches to pain management following total knee replacement surgery as well as analysis of the benefit of implementing Clinical Pathways for total knee replacement. He is also collaborating on a study investigating the effect of pre-operative synovitis in patients with osteoarthritis of the knee and its effect on range of motion and stiffness following this procedure.
Dr. Cornell earned his medical degree at Weill Cornell Medical College and completed his residency in the Department of Orthopedic Surgery at Hospital for Special Surgery and The New York Hospital, in affiliation with Weill Cornell Medical College. He finished a Fellowship in Orthopedic Traumatology at the University of Washington School of Medicine in Seattle, Washington. Board certified by the American Board of Orthopaedic Surgeons, Dr. Cornell is a Fellow of the American Academy of Orthopaedic Surgeons and the American College of Surgeons.
Learn more about the new HSS Orthopedics at Stamford Health.
About HSS | Hospital for Special Surgery
HSS is the world’s leading academic medical center focused on musculoskeletal health. At its core is Hospital for Special Surgery, nationally ranked No. 1 in orthopedics (for the ninth consecutive year) and No. 3 in rheumatology by U.S.News & World Report (2018-2019). Founded in 1863, the Hospital has one of the lowest infection rates in the country and was the first in New York State to receive Magnet Recognition for Excellence in Nursing Service from the American Nurses Credentialing Center four consecutive times. The global standard total knee replacement was developed at HSS in 1969. An affiliate of Weill Cornell Medical College, HSS has a main campus in New York City and facilities in New Jersey, Connecticut and in the Long Island and Westchester County regions of New York State. In 2017 HSS provided care to 135,000 patients and performed more than 32,000 surgical procedures. People from all 50 U.S. states and 80 countries travelled to receive care at HSS. In addition to patient care, HSS leads the field in research, innovation and education. The HSS Research Institute comprises 20 laboratories and 300 staff members focused on leading the advancement of musculoskeletal health through prevention of degeneration, tissue repair and tissue regeneration. The HSS Global Innovation Institute was formed in 2016 to realize the potential of new drugs, therapeutics and devices. The culture of innovation is accelerating at HSS as 130 new idea submissions were made to the Global Innovation Institute in 2017 (almost 3x the submissions in 2015). The HSS Education Institute is the world’s leading provider of education on the topic on musculoskeletal health, with its online learning platform offering more than 600 courses to more than 21,000 medical professional members worldwide. Through HSS Global Ventures, the institution is collaborating with medical centers and other organizations to advance the quality and value of musculoskeletal care and to make world-class HSS care more widely accessible nationally and internationally.